Department of Obstetrics and Gynecology - Division of Gynecological Oncology.
The University of Torino School of Medicine- Torino Italy.
 | piero.sismondi@unito.it |
Piero Sismondi is Professor Emeritus of Gynecological Oncology at the University of Torino School of Medicine. He has been, up to november 2011, Full Professor of Gynecological Oncology at the University of Torino School of Medicine, Director of the Postgraduate School in Obstetrics and Gynaecology at the University of Torino School of Medicine and Head of the Academic Division of Obstetrics and Gynaecology, Gynecologic Oncology and Breast Diseases at the Mauriziano Hospital in Torino, Italy. At present he is Consultant at the Mauriziano Umberto I Hospital in Torino.
Dr. Sismondi completed his MD and specialist training in obstetrics and gynecology and clinical oncology at the University of Torino Medical School, followed by a fellowship at the Institute Gustave-Roussy in Paris, France, and clinical fellowships in the USA (including the Memorial Sloan-Kettering Cancer Center in New York, the University of Texas M. D. Anderson Cancer Center, the Jackson Memorial Hospital in Miami and the UCI in Irvine), specializing in breast and pelvic surgery and oncology.
Dr Sismondi has participated in several clinical trials, including those investigating the clinical relevance of tissue and serum prognostic markers in the management of breast cancer, and the role of estrogen receptors as predictors of response to hormonal treatments. He has developed a special interest in the relationship between hormonal influences and breast cancer risk, and is involved in several biological and clinical studies concerning the safety of hormonal replacement therapy in breast cancer survivors. In 1993 he has developed, together with professor Daniel Chassagne and other Colleagues a glossary of complications of gynecologic cancer treatments that is still the reference standard for complications reporting.
Dr Sismondi is member of many Scientific Societies, of the Torino Academy of Medicine and of the New York Academy of Sciences; is a founding member of the Société Française d'Oncologie Gynécologique, and the International Gynecologic Cancer Society. He has served as President of the Italian Society for Gynecological Oncology and of the Italian Menopause Society, as counselor and secretary of the European Society of Gynecological Oncology.
Dr. Sismondi completed his MD and specialist training in obstetrics and gynecology and clinical oncology at the University of Torino Medical School, followed by a fellowship at the Institute Gustave-Roussy in Paris, France, and clinical fellowships in the USA (including the Memorial Sloan-Kettering Cancer Center in New York, the University of Texas M. D. Anderson Cancer Center, the Jackson Memorial Hospital in Miami and the UCI in Irvine), specializing in breast and pelvic surgery and oncology.
Dr Sismondi has participated in several clinical trials, including those investigating the clinical relevance of tissue and serum prognostic markers in the management of breast cancer, and the role of estrogen receptors as predictors of response to hormonal treatments. He has developed a special interest in the relationship between hormonal influences and breast cancer risk, and is involved in several biological and clinical studies concerning the safety of hormonal replacement therapy in breast cancer survivors. In 1993 he has developed, together with professor Daniel Chassagne and other Colleagues a glossary of complications of gynecologic cancer treatments that is still the reference standard for complications reporting.
Dr Sismondi is member of many Scientific Societies, of the Torino Academy of Medicine and of the New York Academy of Sciences; is a founding member of the Société Française d'Oncologie Gynécologique, and the International Gynecologic Cancer Society. He has served as President of the Italian Society for Gynecological Oncology and of the Italian Menopause Society, as counselor and secretary of the European Society of Gynecological Oncology.
